Prevents the establishment of cellular antiviral state by blocking the cellular IRF7-mediated innate immunity. May also inhibit viral replication by modulating BRLF1 activity. Interacts with host IRF7; this interaction inhibits IRF7 dimerization, thereby altering its function in immunity. Interacts with BRLF1. Belongs to the epstein-barr virus LF2 family.